Shin Mineishi Selected Research

Shin Mineishi Research Topics

Disease

20	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 03/2002
10	Neoplasms (Cancer) 10/2021 - 04/2003
10	Leukemia 01/2020 - 04/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2013
7	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 04/2002
4	Infections 01/2021 - 03/2002
4	Bronchiolitis Obliterans Syndrome 01/2019 - 06/2003
4	Lymphoma (Lymphomas) 01/2019 - 04/2002
3	Multiple Myeloma 01/2019 - 10/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 12/2004
2	Philadelphia Chromosome 01/2017 - 12/2004
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 03/2016 - 08/2012
1	COVID-19 01/2021
1	Seizures (Absence Seizure) 01/2019
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Toxoplasmosis 03/2017
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2017
1	Cerebral Toxoplasmosis 03/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Hemorrhage 03/2016
1	Hypotension (Low Blood Pressure) 03/2016
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2015
1	Lung Injury 07/2012
1	Lung Diseases (Lung Disease) 07/2012
1	Viremia 07/2012
1	Bacteremia 07/2012
1	Systemic Scleroderma (Systemic Sclerosis) 05/2011
1	Acute Kidney Injury (Acute Renal Failure) 05/2011
1	Cryptogenic Organizing Pneumonia 07/2007
1	Transfusion-Related Acute Lung Injury 11/2003
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2002
1	Hemolysis 07/2002
1	Hepatitis B 03/2002

Drug/Important Bio-Agent (IBA)

7	Busulfan (Busulfex)FDA Link 01/2019 - 04/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2004
3	fludarabineIBA 10/2022 - 10/2007
3	Chimeric Antigen ReceptorsIBA 01/2017 - 05/2015
3	Etanercept (Enbrel)FDA Link 10/2012 - 02/2008
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2016
2	Clofarabine (Clolar)FDA Link 09/2018 - 10/2011
2	Monoclonal AntibodiesIBA 01/2017 - 01/2017
2	defibrotideIBA 03/2016 - 08/2012
2	Methylprednisolone FDA LinkGeneric 02/2008 - 12/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2007 - 11/2002
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2003 - 04/2002
1	Interleukin-2 (IL2)IBA 10/2021
1	Isoantigens (Alloantigen)IBA 10/2021
1	Cancer VaccinesIBA 10/2021
1	Decitabine FDA Link 01/2021
1	VaccinesIBA 01/2021
1	avelumabIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Carmustine (FIVB)FDA Link 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	2-aminoethylmethyl sulfoneIBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 03/2017
1	Pentamidine (NebuPent)FDA LinkGeneric 03/2017
1	LigandsIBA 02/2016
1	Proteasome InhibitorsIBA 01/2016
1	AntigensIBA 01/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Biological ProductsIBA 11/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2015
1	Histone MethyltransferasesIBA 12/2013
1	Filgrastim (Neupogen)FDA Link 10/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2012
1	Histones (Histone)IBA 02/2012
1	Sirolimus (Rapamycin)FDA Link 01/2011
1	ElafinIBA 01/2010
1	1-dodecylpyridoxal (PLD)IBA 10/2009
1	liposomal doxorubicin (Doxil)FDA Link 10/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2009
1	Bortezomib (Velcade)FDA Link 10/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2004
1	thymoglobulin FDA Link 12/2004
1	AntibodiesIBA 11/2003
1	Interferon-alpha (Interferon Alfa)IBA 11/2002
1	purineIBA 04/2002
1	Cladribine FDA LinkGeneric 04/2002
1	SteroidsIBA 03/2002

Therapy/Procedure

17	Hematopoietic Stem Cell Transplantation 10/2022 - 11/2003
11	Therapeutics 01/2020 - 03/2002
10	Transplantation 10/2021 - 07/2002
10	Cell Transplantation 12/2019 - 08/2003
10	Stem Cell Transplantation 01/2016 - 04/2002
3	Molecular Targeted Therapy 01/2020 - 01/2016
3	Homologous Transplantation 06/2015 - 04/2002
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
2	Immunotherapy 01/2019 - 01/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2010 - 01/2010
1	Bridge Therapy 01/2016
1	Duration of Therapy 07/2012
1	Blood Transfusion (Blood Transfusions) 11/2003